503 related articles for article (PubMed ID: 9058647)
1. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
Wallberg-Jonsson S; Ohman ML; Dahlqvist SR
J Rheumatol; 1997 Mar; 24(3):445-51. PubMed ID: 9058647
[TBL] [Abstract][Full Text] [Related]
2. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
[TBL] [Abstract][Full Text] [Related]
3. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
Uddhammar A; Eriksson AL; Nyström L; Stenling R; Rantapää-Dahlqvist S
J Rheumatol; 2002 Apr; 29(4):737-42. PubMed ID: 11950015
[TBL] [Abstract][Full Text] [Related]
4. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
5. Prediction of mortality in rheumatoid arthritis based on disease activity markers.
Book C; Saxne T; Jacobsson LT
J Rheumatol; 2005 Mar; 32(3):430-4. PubMed ID: 15742433
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular death in rheumatoid arthritis: a population-based study.
Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
[TBL] [Abstract][Full Text] [Related]
7. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin?
Troelsen LN; Garred P; Jacobsen S
J Rheumatol; 2010 Mar; 37(3):536-43. PubMed ID: 20110521
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
[TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
Kung M; Störk S; Angermann CE
Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
[TBL] [Abstract][Full Text] [Related]
10. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden.
Bergström U; Jacobsson LT; Turesson C
Rheumatology (Oxford); 2009 Dec; 48(12):1600-5. PubMed ID: 19858122
[TBL] [Abstract][Full Text] [Related]
13. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
Van Doornum S; Brand C; King B; Sundararajan V
Arthritis Rheum; 2006 Jul; 54(7):2061-8. PubMed ID: 16802340
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
15. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.
Sihvonen S; Korpela M; Mustonen J; Huhtala H; Karstila K; Pasternack A
J Rheumatol; 2006 Sep; 33(9):1740-6. PubMed ID: 16881099
[TBL] [Abstract][Full Text] [Related]
16. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.
Björnådal L; Baecklund E; Yin L; Granath F; Klareskog L; Ekbom A
J Rheumatol; 2002 May; 29(5):906-12. PubMed ID: 12022348
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.
Gonzalez-Gay MA; Gonzalez-Juanatey C; Lopez-Diaz MJ; Piñeiro A; Garcia-Porrua C; Miranda-Filloy JA; Ollier WE; Martin J; Llorca J
Arthritis Rheum; 2007 Feb; 57(1):125-32. PubMed ID: 17266100
[TBL] [Abstract][Full Text] [Related]
18. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
20. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
